AB loop engineered ferritin nanocages for drug loading under benign experimental conditions

Area of Science:

• Biotechnology
• Nanotechnology
• Drug Delivery Systems

Background:

• Human ferritin is a potential nanocarrier for drug delivery.
• Current methods require extreme acidic conditions (pH ≤ 2.0) for drug encapsulation.
• This limits the application of ferritin-based drug delivery systems.

Purpose of the Study:

• To engineer a novel human ferritin variant for drug encapsulation under mild conditions.
• To overcome the limitations of extreme pH requirements for ferritin-based drug loading.
• To develop a versatile nanocage for improved therapeutic applications.

Main Methods:

• Engineering the AB loop of the human ferritin protein.
• Characterizing the pH-dependent disassembly and reassembly properties of the engineered ferritin variant.
• Assessing the encapsulation efficiency of drugs under mild conditions.

Main Results:

• A new ferritin variant was successfully engineered without creating new pores.
• The engineered ferritin variant demonstrated pH-responsive disassembly at pH 3.0 or 4.0.
• Reassembly of the ferritin nanocage occurred at neutral pH (7.0).
• This enabled drug encapsulation under significantly milder conditions than previously possible.

Conclusions:

• The engineered ferritin variant offers a promising platform for mild-condition drug encapsulation.
• This advancement expands the potential of ferritin as a nanocarrier for sensitive therapeutic agents.
• The pH-responsive nature allows for controlled drug release strategies.